您的浏览器禁用了JavaScript（一种计算机语言，用以实现您与网页的交互），请解除该禁用，或者联系我们。 [美股招股说明书]：Generation Essentials Group-A美股招股说明书(2025-07-11版) - 发现报告
回到首页 AI 搜索 发现报告 发现数据
发现专题
专题报告 专题百科
研选报告 定制报告 VIP 权益 发现大使
行业研究公司研究宏观策略财报招股书会议纪要seedance2.0低空经济DeepSeekAIGC大模型

Generation Essentials Group-A美股招股说明书(2025-07-11版)

2025-07-11 美股招股说明书 黄崇贵-中国医药城15189901173
报告封面

This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated July10, 2025 (as supplemented or amended from time to time, the “Prospectus”), which forms a part of our Registration Statement on Form F-1 (Registration No. 333-288278),as amended and supplemented, with the information contained in our Current Report onForm 6-K, furnished with the Securities and Exchange Commission on July 9, 2025. The Prospectus relates to (i) the issuance by TheGeneration Essentials Group of up to 16,220,000 Ordinary Shares upon exercise of the Warrants, and (ii) the offer and resale from successors in interest (that receive any of the securities as a gift, distribution, or other non-sale related transfer) of up to (a) 57,401,944Ordinary Shares (including 11,120,000 Ordinary Shares issuable upon the exercise of the Sponsor Warrants), and (b) up to 11,120,000Sponsor Warrants.This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and maynot be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. Thisprospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information inthe Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement. We may further amend or supplement the Prospectus and this prospectus supplement from time to time by filing amendmentsor supplements as required. You should read the entire Prospectus, this prospectus supplement and any amendments or supplements for a discussion of information that should be considered in connection with an investment in our securities.Neither the U.S. Securities and Exchange Commission nor any other regulatory body has approved or disapproved of the contrary is a criminal offense.The date of this prospectus supplement is July 11, 2025. Title:Chief Financial OfficerDate: July 9, 2025

点击免费查看完整报告